Scott W. Mcneil
Vancouver, BC V6T1Z1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Carboxylic- and Amide Donor-Functionalized Pyridine-N-trans-Substituted Cyclen-Based Chelators for 203Pb/212Pb Theranostic Radiopharmaceuticals.
Journal: Inorganic chemistry
Published: October 25, 2025
Chelating [227Th]Th4+ for Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors.
Journal: Bioconjugate chemistry
Published: May 10, 2025
Preclinical evaluation of [225Ac]Ac-crown-TATE - An alpha-emitting radiopharmaceutical for neuroendocrine tumors.
Journal: Nuclear medicine and biology
Published: April 08, 2024
Obesity medications: A narrative review of current and emerging agents.
Journal: Osteoarthritis and cartilage open
Published: January 16, 2024
Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH.
Journal: Nuclear medicine and biology
Published: December 18, 2023
The Role of Engineering Ethics in Mitigating Corruption in Infrastructure Systems Delivery.
Journal: Science and engineering ethics
Published: June 28, 2023
Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE-A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours.
Journal: Molecules (Basel, Switzerland)
Published: February 28, 2023
Cyclotron production of 103Pd using a liquid target.
Journal: Nuclear medicine and biology
Published: November 04, 2022
Production of Co-58m in a siphon-style liquid target on a medical cyclotron.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Published: October 25, 2022
Determination of distribution coefficients of mercury and gold on selected extraction chromatographic resins - towards an improved separation method of mercury-197 from proton-irradiated gold targets.
Journal: Journal of chromatography. A
Published: October 03, 2022
Last Updated: 09/26/2026